Skip to main content

Table 4 Overall survival

From: The prognostic value of nestin expression in newly diagnosed glioblastoma: Report from the Radiation Therapy Oncology Group

  Low Intermediate High
Months % Alive No. at Risk % Alive No. at Risk % Alive No. at Risk
0 100% 17 100% 70 100% 66
12 59% 10 49% 34 48% 32
24 29% 5 16% 11 12% 8
36 18% 3 5% 3 5% 3
48 12% 1 0 0 2% 1
60 12% 1 0 0 2% 1
Median Dead/Total 13.3 mo. 16/17 11.8 mo. 69/70 11.6 mo. 65/66
  1. Pairwise Comparisons using Log-rank test: Low vs. Intermediate (0.18), Low vs. High (0.16), Intermediate vs. High (0.80).